Lindbrook Capital, LLC - SERES THERAPEUTICS INC ownership

SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of SERES THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,226
-27.9%
515
+45.1%
0.00%
Q2 2023$1,700
-35.1%
355
-23.2%
0.00%
Q1 2023$2,620
+31.8%
462
+30.1%
0.00%
Q4 2022$1,988
-33.7%
355
-20.6%
0.00%
-100.0%
Q3 2022$3,0004470.00%
Other shareholders
SERES THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 23,117,045$110,730,6464.94%
Lion Point Capital, LP 691,803$3,313,7361.50%
Eversept Partners, LP 3,076,756$14,737,6611.23%
Soleus Capital Management, L.P. 2,045,983$9,800,2591.09%
Knott David M Jr 470,000$2,2510.90%
GREAT POINT PARTNERS LLC 938,067$4,493,3410.88%
Simplify Asset Management Inc. 550,626$2,637,4990.35%
Delphia (USA) Inc. 33,913$162,4430.26%
Alpha DNA Investment Management LLC 138,536$663,5870.22%
Avoro Capital Advisors LLC 2,500,000$11,975,0000.16%
View complete list of SERES THERAPEUTICS INC shareholders